Alkermes (ALKS) Market Capitalization (2010 - 2026)

Alkermes (ALKS) has reported Market Capitalization for 17 consecutive years, with $8.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 85.91% year-over-year to $8.8 billion in Q2 2026; TTM through Jun 2026 was $8.8 billion, a 85.91% increase from a year earlier, with the FY2025 full-year figure at $4.6 billion, down 0.65% from the prior year.
• Market Capitalization was $8.8 billion for Q2 2026 at Alkermes, up from $5.9 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $8.8 billion in Q2 2026 and troughed at $3.7 billion in Q3 2022.
• A 5-year average of $4.9 billion and a median of $4.7 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization declined 26.42% in 2022 and surged 85.91% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $4.3 billion in 2022, then advanced by 7.84% to $4.6 billion in 2023, then increased by 0.69% to $4.7 billion in 2024, then decreased by 0.65% to $4.6 billion in 2025, then soared by 89.46% to $8.8 billion in 2026.
• The last three Market Capitalization figures came in at $8.8 billion (Q2 2026), $5.9 billion (Q1 2026), and $4.6 billion (Q4 2025), per Business Quant data.